Characterizing dosimetric uncertainties to tumour volume and organs at risk in rectal cancer

Characterizing dosimetric uncertainties to tumour volume and organs at risk in rectal cancer

Dades bibliogràfiques
Autors principals:	Babatunde, O, O'Cathail, S, Cooke, R, George, B, Robinson, M, Van Den Heuvel, F, Hawkins, M
Format:	Conference item
Publicat:	Elsevier 2019

Ítems similars

Improving outcomes for resistant rectal cancer
per: O'Cathail, S
Publicat: (2019)

KEAP1-NRF2 pathway as a modulator of response to radiation in rectal cancer
per: O'Cathail, S, et al.
Publicat: (2018)

SBRT Pelvic re-irradiation: 2cm "rind" around PTV and small bowel dosimetry of rectal recurrences
per: O'Cathail, S, et al.
Publicat: (2019)

Stereotactic body radiotherapy for moderately central and ultra-central oligometastatic disease: Initial outcomes
per: Rosie Cooke, et al.
Publicat: (2020-03-01)

Are all colorectal oligometastases equal?
per: O'Cathail, S, et al.
Publicat: (2018)

Immune Checkpoint Inhibition as a Strategy in the Neoadjuvant Treatment of Locally Advanced Rectal Cancer
per: Catherine R. Hanna, et al.
Publicat: (2021-05-01)

Science in focus: Bioinformatics part 1 – Lost in translation
per: O'Cathail, SM, et al.
Publicat: (2019)

PV-0625 Biological factors influencing outcomes in SBRT for colorectal cancer oligometastases (OM)
per: O'Cathail, S, et al.
Publicat: (2019)

A Review of Scheduling Strategies for Radiotherapy and Immune Checkpoint Inhibition in Locally Advanced Rectal Cancer
per: Lydia Melissourgou-Syka, et al.
Publicat: (2023-11-01)

The in-silico feasibility of dose escalated, hypofractionated radiotherapy for rectal cancer
per: Lynsey Devlin, et al.
Publicat: (2022-09-01)

Combining oncolytic adenovirus with radiation – a paradigm for the future of radiosensitization
per: O'Cathail, S, et al.
Publicat: (2017)

Dosimetric evaluation of rectal dose in HDR intracavitary brachytherapy of cervix
per: A. Khan, et al.
Publicat: (2023-05-01)

A phase 1 trial of the safety, tolerability and biological effects of intravenous Enadenotucirev, a novel oncolytic virus, in combination with chemoradiotherapy in locally advanced rectal cancer (CEDAR)
per: Séan M. O’Cathail, et al.
Publicat: (2020-06-01)

Geometric and dosimetric evaluation of deep learning-based organs at risk auto-segmentation for rectal cancer
per: GUO Hongbo, et al.
Publicat: (2022-04-01)

The dosimetric impact of deep learning-based auto-segmentation of organs at risk on nasopharyngeal and rectal cancer
per: Hongbo Guo, et al.
Publicat: (2021-06-01)

Dosimetric evaluation in breast tumours: comparison of three techniques
per: João Marques, et al.
Publicat: (2015-12-01)

Evaluation of rectal volume correlation with dosimetric parameters during optimized intracavitary high-dose-rate brachytherapy in cervical cancer
per: Hodjatollah Shahbazian, et al.
Publicat: (2020-04-01)

NRF2 Mediates Therapeutic Resistance to Chemoradiation in Colorectal Cancer through a Metabolic Switch
per: Séan M. O’Cathail, et al.
Publicat: (2021-08-01)

Dosimetric comparison of VMAT plans in preoperative short-course rectal radiotherapy
per: Qiong Zhou, et al.
Publicat: (2024-12-01)

The Use of Patient-Facing Teleconsultations in the National Health Service: Scoping Review
per: O'Cathail, Micheal, et al.
Publicat: (2020-03-01)

Patient-reported outcomes in PROSPECT trial (Alliance N1048) – FOLFOX is not a panacea
per: Sean M. O'Cathail, et al.
Publicat: (2023-11-01)

Dosimetric Evaluation Study of 10-MV FFF Used in SBRT for Lung Tumours
per: Mohamed I. Soliman, et al.
Publicat: (2023-09-01)

Radiotherapy for Rectal Cancer and Radiation-Induced Malignancies from Epidemiological and Dosimetric Data
per: Stefanos Kachris, et al.
Publicat: (2024-12-01)

Dosimetric Impact of Bladder Volumetric Changes During Helical Radiotherapy for Rectal Cancer
per: Sibel Karaca, et al.
Publicat: (2022-03-01)

Comparison of dosimetric analysis of organs at risk and target volumes for ovoids and cylinders in endometrial carcinoma
per: Yashaswini BR, et al.
Publicat: (2023-12-01)

Investigating rectal toxicity associated dosimetric features with deformable accumulated rectal surface dose maps for cervical cancer radiotherapy
per: Jiawei Chen, et al.
Publicat: (2018-07-01)

Delineation uncertainties of tumour volumes on MRI of head and neck cancer patients
per: Ruta Zukauskaite, et al.
Publicat: (2022-09-01)

Dosimetric analysis and comparison of reduced longitudinal cranial margins of VMAT-IMRT of rectal cancer
per: Hendrik Dapper, et al.
Publicat: (2018-09-01)

Dosimetric evaluation of magnetic resonance-generated synthetic CT for radiation treatment of rectal cancer.
per: Hesheng Wang, et al.
Publicat: (2018-01-01)

Geometrical and dosimetric evaluation of breast target volume auto-contouring
per: Rita Simões, et al.
Publicat: (2019-10-01)

Initial results from the Royal College of Radiologists' UK National Audit of Anal Cancer Radiotherapy 2015
per: Muirhead, R, et al.
Publicat: (2016)

Stepwise multicenter introduction of intensity modulated radiation therapy for anal cancer in the United Kingdom: From consensus guidance to large-scale prospective audit, prior to future clinical trials
per: Gilbert, D, et al.
Publicat: (2016)

Dosimetric analysis of varying cord planning organ at risk volume in spine stereotactic body radiation therapy
per: Dawn Owen, MD, PhD, et al.
Publicat: (2016-01-01)

Potential benefits of dosimetric VMAT tracking verified with 3D film measurements
per: Crijns, W, et al.
Publicat: (2016)

Dosimetric parameters predict toxicity in chemoradiotherapy with nelfinavir for pancreatic cancer
per: Holyoake, D, et al.
Publicat: (2016)

A comprehensive dosimetric comparison of four target volume definitions for pancreatic cancer and their influence on lymphatics and organs at risk
per: Fokas, E, et al.
Publicat: (2013)

Predictors of radiation-induced late rectal toxicity in prostate cancer treatment: a volumetric and dosimetric analysis
per: Simon K. B. Spohn, et al.
Publicat: (2024-04-01)

Expanding the Utilization of Rectal Spacer Hydrogel for Larger Prostate Glands (>80 cc): Feasibility and Dosimetric Outcomes
per: Marcio Fagundes, MD, et al.
Publicat: (2021-05-01)

Novel prostate brachytherapy technique: improved dosimetric and clinical outcome.
per: Nobes, J, et al.
Publicat: (2008)

Novel prostate brachytherapy technique: improved dosimetric and clinical outcome.
per: Nobes, J, et al.
Publicat: (2008)